APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmacovigilance Solutions

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmacovigilance Solutions Market Outlook and Growth Opportunities 2026

3 May 2026195 pages

Choose your research edition.

Industry ResearchPharmacovigilance Solutions Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacovigilance Solutions Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Pharmacovigilance Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacovigilance Solutions Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmacovigilance Solutions Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Pharmacovigilance Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmacovigilance Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmacovigilance Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmacovigilance Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmacovigilance Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmacovigilance Solutions market include Eurofins Scientific, Accenture, PPD, SGS, WuXi AppTec, Cognizant, ICON, IQVIA and Parexel, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmacovigilance Solutions market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmacovigilance Solutions and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmacovigilance Solutions revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmacovigilance Solutions market.

Pharmacovigilance Solutions Segment by Company

Eurofins Scientific

Accenture

PPD

SGS

WuXi AppTec

Cognizant

ICON

IQVIA

Parexel

United BioSource

Vial

Wipro

PrimeVigilance

Aixial Group

TransPerfect

ProPharma

HCLTech

QbD Group

Quanticate

Qinecsa Solutions

Veristat

Veeda

Tigermed

Clarivate

Pharmacovigilance Solutions Segment by Type

Writing and Submitting Documents and Reports

Security Database System Services and Data Management

Signal Detection and Evaluation

Training and Consulting

Other

Pharmacovigilance Solutions Segment by Application

Preclinical

Clinical Phase

Post-launch

Pharmacovigilance Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmacovigilance Solutions status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmacovigilance Solutions key companies, revenue, market share, and recent developments.

3. To split the Pharmacovigilance Solutions breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmacovigilance Solutions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmacovigilance Solutions significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmacovigilance Solutions competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacovigilance Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacovigilance Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacovigilance Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacovigilance Solutions industry.

Chapter 3: Detailed analysis of Pharmacovigilance Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmacovigilance Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmacovigilance Solutions in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmacovigilance Solutions Industry Trends Table 2. Pharmacovigilance Solutions Industry Drivers Table 3. Pharmacovigilance Solutions Industry Opportunities and Challenges Table 4. Pharmacovigilance Solutions Industry Restraints Table 5. Global Pharmacovigilance Solutions Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmacovigilance Solutions Revenue Share by Company (2021-2026) Table 7. Global Pharmacovigilance Solutions Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmacovigilance Solutions Key Company Manufacturing Base & Headquarters Table 9. Global Pharmacovigilance Solutions Company, Product Type & Application Table 10. Global Pharmacovigilance Solutions Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmacovigilance Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Writing and Submitting Documents and Reports Table 15. Significant Companies of Security Database System Services and Data Management Table 16. Significant Companies of Signal Detection and Evaluation Table 17. Significant Companies of Training and Consulting Table 18. Significant Companies of Other Table 19. Global Pharmacovigilance Solutions Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Pharmacovigilance Solutions Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Pharmacovigilance Solutions Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Pharmacovigilance Solutions Sales Value Share by Type (2021-2026) Table 23. Global Pharmacovigilance Solutions Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Preclinical Table 25. Significant Companies of Clinical Phase Table 26. Significant Companies of Post-launch Table 27. Global Pharmacovigilance Solutions Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pharmacovigilance Solutions Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Pharmacovigilance Solutions Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Pharmacovigilance Solutions Sales Value Share by Application (2021-2026) Table 31. Global Pharmacovigilance Solutions Sales Value Share by Application (2027-2032) Table 32. Global Pharmacovigilance Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pharmacovigilance Solutions Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Pharmacovigilance Solutions Sales Value Share by Region (2021-2026) Table 35. Global Pharmacovigilance Solutions Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Pharmacovigilance Solutions Sales Value Share by Region (2027-2032) Table 37. Global Pharmacovigilance Solutions Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pharmacovigilance Solutions Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Pharmacovigilance Solutions Sales Value Market Share by Country (2021-2026) Table 40. Global Pharmacovigilance Solutions Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Pharmacovigilance Solutions Sales Value Market Share by Country (2027-2032) Table 42. Eurofins Scientific Company Information Table 43. Eurofins Scientific Business Overview Table 44. Eurofins Scientific Pharmacovigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Eurofins Scientific Pharmacovigilance Solutions Product Portfolio Table 46. Eurofins Scientific Recent Development Table 47. Accenture Company Information Table 48. Accenture Business Overview Table 49. Accenture Pharmacovigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Accenture Pharmacovigilance Solutions Product Portfolio Table 51. Accenture Recent Development Table 52. PPD Company Information Table 53. PPD Business Overview Table 54. PPD Pharmacovigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. PPD Pharmacovigilance Solutions Product Portfolio Table 56. PPD Recent Development Table 57. SGS Company Information Table 58. SGS Business Overview Table 59. SGS Pharmacovigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. SGS Pharmacovigilance Solutions Product Portfolio Table 61. SGS Recent Development Table 62. WuXi AppTec Company Information Table 63. WuXi AppTec Business Overview Table 64. WuXi AppTec Pharmacovigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. WuXi AppTec Pharmacovigilance Solutions Product Portfolio Table 66. WuXi AppTec Recent Development Table 67. Cognizant Company Information Table 68. Cognizant Business Overview Table 69. Cognizant Pharmacovigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Cognizant Pharmacovigilance Solutions Product Portfolio Table 71. Cognizant Recent Development Table 72. ICON Company Information Table 73. ICON Business Overview Table 74. ICON Pharmacovigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. ICON Pharmacovigilance Solutions Product Portfolio Table 76. ICON Recent Development Table 77. IQVIA Company Information Table 78. IQVIA Business Overview Table 79. IQVIA Pharmacovigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. IQVIA Pharmacovigilance Solutions Product Portfolio Table 81. IQVIA Recent Development Table 82. Parexel Company Information Table 83. Parexel Business Overview Table 84. Parexel Pharmacovigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Parexel Pharmacovigilance Solutions Product Portfolio Table 86. Parexel Recent Development Table 87. United BioSource Company Information Table 88. United BioSource Business Overview Table 89. United BioSource Pharmacovigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. United BioSource Pharmacovigilance Solutions Product Portfolio Table 91. United BioSource Recent Development Table 92. Vial Company Information Table 93. Vial Business Overview Table 94. Vial Pharmacovigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Vial Pharmacovigilance Solutions Product Portfolio Table 96. Vial Recent Development Table 97. Wipro Company Information Table 98. Wipro Business Overview Table 99. Wipro Pharmacovigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Wipro Pharmacovigilance Solutions Product Portfolio Table 101. Wipro Recent Development Table 102. PrimeVigilance Company Information Table 103. PrimeVigilance Business Overview Table 104. PrimeVigilance Pharmacovigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. PrimeVigilance Pharmacovigilance Solutions Product Portfolio Table 106. PrimeVigilance Recent Development Table 107. Aixial Group Company Information Table 108. Aixial Group Business Overview Table 109. Aixial Group Pharmacovigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Aixial Group Pharmacovigilance Solutions Product Portfolio Table 111. Aixial Group Recent Development Table 112. TransPerfect Company Information Table 113. TransPerfect Business Overview Table 114. TransPerfect Pharmacovigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. TransPerfect Pharmacovigilance Solutions Product Portfolio Table 116. TransPerfect Recent Development Table 117. ProPharma Company Information Table 118. ProPharma Business Overview Table 119. ProPharma Pharmacovigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. ProPharma Pharmacovigilance Solutions Product Portfolio Table 121. ProPharma Recent Development Table 122. HCLTech Company Information Table 123. HCLTech Business Overview Table 124. HCLTech Pharmacovigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. HCLTech Pharmacovigilance Solutions Product Portfolio Table 126. HCLTech Recent Development Table 127. QbD Group Company Information Table 128. QbD Group Business Overview Table 129. QbD Group Pharmacovigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. QbD Group Pharmacovigilance Solutions Product Portfolio Table 131. QbD Group Recent Development Table 132. Quanticate Company Information Table 133. Quanticate Business Overview Table 134. Quanticate Pharmacovigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Quanticate Pharmacovigilance Solutions Product Portfolio Table 136. Quanticate Recent Development Table 137. Qinecsa Solutions Company Information Table 138. Qinecsa Solutions Business Overview Table 139. Qinecsa Solutions Pharmacovigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Qinecsa Solutions Pharmacovigilance Solutions Product Portfolio Table 141. Qinecsa Solutions Recent Development Table 142. Veristat Company Information Table 143. Veristat Business Overview Table 144. Veristat Pharmacovigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Veristat Pharmacovigilance Solutions Product Portfolio Table 146. Veristat Recent Development Table 147. Veeda Company Information Table 148. Veeda Business Overview Table 149. Veeda Pharmacovigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Veeda Pharmacovigilance Solutions Product Portfolio Table 151. Veeda Recent Development Table 152. Tigermed Company Information Table 153. Tigermed Business Overview Table 154. Tigermed Pharmacovigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Tigermed Pharmacovigilance Solutions Product Portfolio Table 156. Tigermed Recent Development Table 157. Clarivate Company Information Table 158. Clarivate Business Overview Table 159. Clarivate Pharmacovigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Clarivate Pharmacovigilance Solutions Product Portfolio Table 161. Clarivate Recent Development Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Pharmacovigilance Solutions Product Image Figure 2. Global Pharmacovigilance Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmacovigilance Solutions Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Writing and Submitting Documents and Reports Image Figure 8. Security Database System Services and Data Management Image Figure 9. Signal Detection and Evaluation Image Figure 10. Training and Consulting Image Figure 11. Other Image Figure 12. Global Pharmacovigilance Solutions Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Pharmacovigilance Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Pharmacovigilance Solutions Sales Value Share by Type (2021-2032) Figure 15. Preclinical Image Figure 16. Clinical Phase Image Figure 17. Post-launch Image Figure 18. Global Pharmacovigilance Solutions Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pharmacovigilance Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Pharmacovigilance Solutions Sales Value Share by Application (2021-2032) Figure 21. Global Pharmacovigilance Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Pharmacovigilance Solutions Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Pharmacovigilance Solutions Sales Value (2021-2032) & (US$ Million) Figure 24. North America Pharmacovigilance Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Pharmacovigilance Solutions Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Pharmacovigilance Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Pharmacovigilance Solutions Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Pharmacovigilance Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Pharmacovigilance Solutions Sales Value (2021-2032) & (US$ Million) Figure 30. South America Pharmacovigilance Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Pharmacovigilance Solutions Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Pharmacovigilance Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Writing and Submitting Documents and Reports
  • Security Database System Services and Data Management
  • Signal Detection and Evaluation
  • Training and Consulting
  • Other
Applications
  • Preclinical
  • Clinical Phase
  • Post-launch
Companies covered
  • Eurofins Scientific
  • Accenture
  • PPD
  • SGS
  • WuXi AppTec
  • Cognizant
  • ICON
  • IQVIA
  • Parexel
  • United BioSource
  • Vial
  • Wipro
  • PrimeVigilance
  • Aixial Group
  • TransPerfect
  • ProPharma
  • HCLTech
  • QbD Group
  • Quanticate
  • Qinecsa Solutions
  • Veristat
  • Veeda
  • Tigermed
  • Clarivate

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmacovigilance Solutions Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmacovigilance Solutions Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmacovigilance Solutions Market Dynamics
  1. 2.1 Pharmacovigilance Solutions Industry Trends
  2. 2.2 Pharmacovigilance Solutions Industry Drivers
  3. 2.3 Pharmacovigilance Solutions Industry Opportunities and Challenges
  4. 2.4 Pharmacovigilance Solutions Industry Restraints
3 Pharmacovigilance Solutions Market by Company
  1. 3.1 Global Pharmacovigilance Solutions Company Revenue Ranking in 2025
  2. 3.2 Global Pharmacovigilance Solutions Revenue by Company (2021-2026)
  3. 3.3 Global Pharmacovigilance Solutions Company Ranking (2024-2026)
  4. 3.4 Global Pharmacovigilance Solutions Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmacovigilance Solutions Company Product Type and Application
  6. 3.6 Global Pharmacovigilance Solutions Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmacovigilance Solutions Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmacovigilance Solutions Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmacovigilance Solutions Market by Type
  1. 4.1 Pharmacovigilance Solutions Type Introduction
  2. 4.1.1 Writing and Submitting Documents and Reports
  3. 4.1.2 Security Database System Services and Data Management
  4. 4.1.3 Signal Detection and Evaluation
  5. 4.1.4 Training and Consulting
  6. 4.1.5 Other
  7. 4.2 Global Pharmacovigilance Solutions Sales Value by Type
  8. 4.2.1 Global Pharmacovigilance Solutions Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Pharmacovigilance Solutions Sales Value by Type (2021-2032)
  10. 4.2.3 Global Pharmacovigilance Solutions Sales Value Share by Type (2021-2032)
5 Pharmacovigilance Solutions Market by Application
  1. 5.1 Pharmacovigilance Solutions Application Introduction
  2. 5.1.1 Preclinical
  3. 5.1.2 Clinical Phase
  4. 5.1.3 Post-launch
  5. 5.2 Global Pharmacovigilance Solutions Sales Value by Application
  6. 5.2.1 Global Pharmacovigilance Solutions Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmacovigilance Solutions Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pharmacovigilance Solutions Sales Value Share by Application (2021-2032)
6 Pharmacovigilance Solutions Regional Value Analysis
  1. 6.1 Global Pharmacovigilance Solutions Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmacovigilance Solutions Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmacovigilance Solutions Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmacovigilance Solutions Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmacovigilance Solutions Sales Value (2021-2032)
  7. 6.3.2 North America Pharmacovigilance Solutions Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmacovigilance Solutions Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmacovigilance Solutions Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmacovigilance Solutions Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmacovigilance Solutions Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmacovigilance Solutions Sales Value (2021-2032)
  16. 6.6.2 South America Pharmacovigilance Solutions Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmacovigilance Solutions Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmacovigilance Solutions Sales Value Share by Country, 2025 VS 2032
7 Pharmacovigilance Solutions Country-level Value Analysis
  1. 7.1 Global Pharmacovigilance Solutions Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmacovigilance Solutions Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmacovigilance Solutions Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmacovigilance Solutions Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmacovigilance Solutions Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmacovigilance Solutions Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmacovigilance Solutions Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eurofins Scientific
  2. 8.1.1 Eurofins Scientific Company Information
  3. 8.1.2 Eurofins Scientific Business Overview
  4. 8.1.3 Eurofins Scientific Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eurofins Scientific Pharmacovigilance Solutions Product Portfolio
  6. 8.1.5 Eurofins Scientific Recent Developments
  7. 8.2 Accenture
  8. 8.2.1 Accenture Company Information
  9. 8.2.2 Accenture Business Overview
  10. 8.2.3 Accenture Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Accenture Pharmacovigilance Solutions Product Portfolio
  12. 8.2.5 Accenture Recent Developments
  13. 8.3 PPD
  14. 8.3.1 PPD Company Information
  15. 8.3.2 PPD Business Overview
  16. 8.3.3 PPD Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  17. 8.3.4 PPD Pharmacovigilance Solutions Product Portfolio
  18. 8.3.5 PPD Recent Developments
  19. 8.4 SGS
  20. 8.4.1 SGS Company Information
  21. 8.4.2 SGS Business Overview
  22. 8.4.3 SGS Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SGS Pharmacovigilance Solutions Product Portfolio
  24. 8.4.5 SGS Recent Developments
  25. 8.5 WuXi AppTec
  26. 8.5.1 WuXi AppTec Company Information
  27. 8.5.2 WuXi AppTec Business Overview
  28. 8.5.3 WuXi AppTec Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  29. 8.5.4 WuXi AppTec Pharmacovigilance Solutions Product Portfolio
  30. 8.5.5 WuXi AppTec Recent Developments
  31. 8.6 Cognizant
  32. 8.6.1 Cognizant Company Information
  33. 8.6.2 Cognizant Business Overview
  34. 8.6.3 Cognizant Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cognizant Pharmacovigilance Solutions Product Portfolio
  36. 8.6.5 Cognizant Recent Developments
  37. 8.7 ICON
  38. 8.7.1 ICON Company Information
  39. 8.7.2 ICON Business Overview
  40. 8.7.3 ICON Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ICON Pharmacovigilance Solutions Product Portfolio
  42. 8.7.5 ICON Recent Developments
  43. 8.8 IQVIA
  44. 8.8.1 IQVIA Company Information
  45. 8.8.2 IQVIA Business Overview
  46. 8.8.3 IQVIA Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  47. 8.8.4 IQVIA Pharmacovigilance Solutions Product Portfolio
  48. 8.8.5 IQVIA Recent Developments
  49. 8.9 Parexel
  50. 8.9.1 Parexel Company Information
  51. 8.9.2 Parexel Business Overview
  52. 8.9.3 Parexel Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Parexel Pharmacovigilance Solutions Product Portfolio
  54. 8.9.5 Parexel Recent Developments
  55. 8.10 United BioSource
  56. 8.10.1 United BioSource Company Information
  57. 8.10.2 United BioSource Business Overview
  58. 8.10.3 United BioSource Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  59. 8.10.4 United BioSource Pharmacovigilance Solutions Product Portfolio
  60. 8.10.5 United BioSource Recent Developments
  61. 8.11 Vial
  62. 8.11.1 Vial Company Information
  63. 8.11.2 Vial Business Overview
  64. 8.11.3 Vial Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Vial Pharmacovigilance Solutions Product Portfolio
  66. 8.11.5 Vial Recent Developments
  67. 8.12 Wipro
  68. 8.12.1 Wipro Company Information
  69. 8.12.2 Wipro Business Overview
  70. 8.12.3 Wipro Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Wipro Pharmacovigilance Solutions Product Portfolio
  72. 8.12.5 Wipro Recent Developments
  73. 8.13 PrimeVigilance
  74. 8.13.1 PrimeVigilance Company Information
  75. 8.13.2 PrimeVigilance Business Overview
  76. 8.13.3 PrimeVigilance Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  77. 8.13.4 PrimeVigilance Pharmacovigilance Solutions Product Portfolio
  78. 8.13.5 PrimeVigilance Recent Developments
  79. 8.14 Aixial Group
  80. 8.14.1 Aixial Group Company Information
  81. 8.14.2 Aixial Group Business Overview
  82. 8.14.3 Aixial Group Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Aixial Group Pharmacovigilance Solutions Product Portfolio
  84. 8.14.5 Aixial Group Recent Developments
  85. 8.15 TransPerfect
  86. 8.15.1 TransPerfect Company Information
  87. 8.15.2 TransPerfect Business Overview
  88. 8.15.3 TransPerfect Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  89. 8.15.4 TransPerfect Pharmacovigilance Solutions Product Portfolio
  90. 8.15.5 TransPerfect Recent Developments
  91. 8.16 ProPharma
  92. 8.16.1 ProPharma Company Information
  93. 8.16.2 ProPharma Business Overview
  94. 8.16.3 ProPharma Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  95. 8.16.4 ProPharma Pharmacovigilance Solutions Product Portfolio
  96. 8.16.5 ProPharma Recent Developments
  97. 8.17 HCLTech
  98. 8.17.1 HCLTech Company Information
  99. 8.17.2 HCLTech Business Overview
  100. 8.17.3 HCLTech Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  101. 8.17.4 HCLTech Pharmacovigilance Solutions Product Portfolio
  102. 8.17.5 HCLTech Recent Developments
  103. 8.18 QbD Group
  104. 8.18.1 QbD Group Company Information
  105. 8.18.2 QbD Group Business Overview
  106. 8.18.3 QbD Group Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  107. 8.18.4 QbD Group Pharmacovigilance Solutions Product Portfolio
  108. 8.18.5 QbD Group Recent Developments
  109. 8.19 Quanticate
  110. 8.19.1 Quanticate Company Information
  111. 8.19.2 Quanticate Business Overview
  112. 8.19.3 Quanticate Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Quanticate Pharmacovigilance Solutions Product Portfolio
  114. 8.19.5 Quanticate Recent Developments
  115. 8.20 Qinecsa Solutions
  116. 8.20.1 Qinecsa Solutions Company Information
  117. 8.20.2 Qinecsa Solutions Business Overview
  118. 8.20.3 Qinecsa Solutions Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Qinecsa Solutions Pharmacovigilance Solutions Product Portfolio
  120. 8.20.5 Qinecsa Solutions Recent Developments
  121. 8.21 Veristat
  122. 8.21.1 Veristat Company Information
  123. 8.21.2 Veristat Business Overview
  124. 8.21.3 Veristat Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Veristat Pharmacovigilance Solutions Product Portfolio
  126. 8.21.5 Veristat Recent Developments
  127. 8.22 Veeda
  128. 8.22.1 Veeda Company Information
  129. 8.22.2 Veeda Business Overview
  130. 8.22.3 Veeda Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Veeda Pharmacovigilance Solutions Product Portfolio
  132. 8.22.5 Veeda Recent Developments
  133. 8.23 Tigermed
  134. 8.23.1 Tigermed Company Information
  135. 8.23.2 Tigermed Business Overview
  136. 8.23.3 Tigermed Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Tigermed Pharmacovigilance Solutions Product Portfolio
  138. 8.23.5 Tigermed Recent Developments
  139. 8.24 Clarivate
  140. 8.24.1 Clarivate Company Information
  141. 8.24.2 Clarivate Business Overview
  142. 8.24.3 Clarivate Pharmacovigilance Solutions Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Clarivate Pharmacovigilance Solutions Product Portfolio
  144. 8.24.5 Clarivate Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst